Bio-Pharm Archives - 17 중 10 번째 페이지

FDA Approves Liga-Chem Bio’s IND for Novel ADC Cancer Therapy

Liga-Chem BioSciences announced that it has received approval from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application for LNCB74, an antibody-drug conjugate (ADC) being…

Jang Jawon

2024-12-11

Cenobamate Proven Effective for Patients in Korea, China, and Japan

SK Biopharmaceuticals announced that its anti-epileptic drug Cenobamate has demonstrated clinical efficacy for patients in Northeast Asia, paving the way for expanding regulatory submissions globally. The company presented Phase 3…

Jang Jawon

2024-12-09

Alteogen Receives USD 20 Million Upfront Payment from Daiichi Sankyo

Alteogen announced that it has received an upfront payment of USD 20 million (approximately KRW 28 billion) from Daiichi Sankyo. Last month, Alteogen granted an exclusive license for its hyaluronidase…

Jang Jawon

2024-12-03

Samsung Bioepis Appoints Kim Kyung-ah as New CEO After 13 Years

Samsung Bioepis announced a leadership change for the first time in 13 years. On the 27th, the company announced that Kim Kyung-ah, Executive Vice President and Head of Development, has…

Cheon Okhyeon

2024-11-27

Daewoong "Ursa Shows Liver Function Improvement in Phase 4 Trial"

Ursa has once again proven its liver function improvement effects through clinical trials. Daewoong Pharmaceutical announced on the 26th that it presented the results of Ursa’s Phase 4 clinical trial…

Cheon Okhyeon

2024-11-26

Celltrion Secures First Approval for Prolia Biosimilar in Korea

Celltrion has received its first approval for a biosimilar of Prolia (denosumab), a treatment for osteoporosis. On the 22nd, Celltrion announced that it obtained simultaneous approvals from the Ministry of…

Cheon Okhyeon

2024-11-22

Samsung Biologics Breaks 5 Trillion KRW in Annual Orders for the First Time

Samsung Biologics has surpassed 5 trillion KRW in annual cumulative orders for the first time since its establishment. On the 20th, Samsung Biologics announced through two disclosures that it had…

Cheon Okhyeon

2024-11-20

FDA Approved VUNO’s AI Chest X-ray Diagnostic Device

Medical AI company VUNO announced on the 19th that its AI-based chest X-ray diagnostic device, VUNO Med-Chest X-ray Triage, has received approval from the U.S. Food and Drug Administration (FDA).…

Jang Jawon

2024-11-19

Lunit Partners with AstraZeneca to Develop ‘AI Pathology Solution’

Lunit, a medical AI company, announced on the 18th that it has signed a strategic collaboration agreement with AstraZeneca to develop an AI digital pathology solution targeting non-small cell lung…

Jang Jawon

2024-11-18

Celltrion Acquires Swiss Pharmaceutical Distributor, iQone Healthcare Switzerland

Celltrion announced on the 15th that it has acquired the Swiss pharmaceutical distribution company "iQone Healthcare Switzerland." The acquisition process was completed this month, with the transaction valued at approximately…

Cheon Okhyeon

2024-11-15